Immune checkpoint inhibitors as a real hope in advanced urothelial carcinoma

Metastatic urothelial cancer is an aggressive disease associated with a poor prognosis. In the first-line setting, platinum-based chemotherapy is the standard of care but resistance rapidly occurs. After failure of platinum-based therapy and in cisplatin-ineligible patients, therapeutic options are...

Descripción completa

Detalles Bibliográficos
Autores principales: Seront, Emmanuel, Catala, Gaëtan, Dermine, Alexandre, Lejeune, Sarah, Rysselinck, Stephane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Science Ltd 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6234462/
https://www.ncbi.nlm.nih.gov/pubmed/30457576
http://dx.doi.org/10.4155/fsoa-2018-0033

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6234462/
https://www.ncbi.nlm.nih.gov/pubmed/30457576
http://dx.doi.org/10.4155/fsoa-2018-0033

Ejemplares similares